1. Home
  2. CYPH vs ECOR Comparison

CYPH vs ECOR Comparison

Compare CYPH & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYPH

Cypherpunk Technologies Inc.

N/A

Current Price

$0.75

Market Cap

73.4M

Sector

Health Care

ML Signal

N/A

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$8.45

Market Cap

81.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
ECOR
Founded
2011
2005
Country
United States
United States
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.4M
81.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CYPH
ECOR
Price
$0.75
$8.45
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
6.8M
176.8K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$32,032,000.00
Revenue This Year
N/A
$33.60
Revenue Next Year
N/A
$30.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
27.20
52 Week Low
$0.49
$4.16
52 Week High
$3.70
$10.50

Technical Indicators

Market Signals
Indicator
CYPH
ECOR
Relative Strength Index (RSI) 43.75 51.73
Support Level $0.54 $8.55
Resistance Level $0.79 $10.37
Average True Range (ATR) 0.11 1.04
MACD -0.02 -0.20
Stochastic Oscillator 31.82 22.82

Price Performance

Historical Comparison
CYPH
ECOR

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About ECOR electroCore Inc.

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

Share on Social Networks: